A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp
Clinical trial NCT00669214 · COMPLETED
Trial details
- NCT number
- NCT00669214
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-01-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.